Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

The procedure may involve making incisions to access the jawbone and using plates, screws, or wires to align and stabilize it.

Antithrombin III is a protein that helps regulate blood clotting by inhibiting clotting factors. Proper function of Antithrombin III is essential for preventing abnormal blood clot formation.

A blood sample is drawn from a vein in your arm and analyzed to measure Antithrombin III levels and activity.

No fasting or special preparation is required. You can eat and drink normally before the test.

Results are generally available within a few hours to 1-2 days, depending on the laboratory’s processing time.

Discuss any abnormal results with your healthcare provider, who will provide guidance on further tests or treatment options based on your specific condition.